Product Overview
Tirzepatide (LY3298176, CAS:2023788‑19‑2) is a synthetic 39‑amino‑acid dual GIP / GLP‑1 receptor agonist peptide, supplied as white‑off‑white lyophilized powder in sealed vials. It is widely used for pre‑clinical laboratory research on metabolic pathways, glucose homeostasis and incretin‑related mechanism studies.
Specifications
- Form: Lyophilized powder (unreconstituted)
- Purity: ≥98%, tested by HPLC & MS
- Molecular Weight: 4813.53 g/mol
- Each batch comes with Certificate of Analysis (COA)
Research Applications
Suitable for in‑vitro and in‑vivo lab research focusing on GIP‑GLP‑1 dual‑agonist signaling, glucose metabolism, insulin sensitivity and metabolic‑related pre‑clinical model studies.
Quality Control
Every production batch undergoes strict laboratory testing including HPLC purity verification. Third‑party test data can be provided upon request to guarantee consistent product quality for your research projects.
Storage & Handling
Store lyophilized powder at ‑20°C, keep away from moisture and direct light. After reconstitution, store at 2‑8°C and use promptly. Avoid repeated freeze‑thaw cycles.
Disclaimer: This product is intended for laboratory research use only. Not for human consumption, clinical or therapeutic application.
Reviews
There are no reviews yet.